The bricks and mortar behind ViraCorp

We have an extensive global network of capabilities and resources

Our Research Facility

Lancaster University

ViraCorp has partnered with the World-Class Lancaster University as the lead research facility for the rigorous testing of all ViraCorp products.

The university’s biomedical facilities and equipment are state-of-the-art, with a CL3 Laboratory and full access to the university’s resources as required for each project.

In the last REF, 91% of Lancaster’s research was rated as either internationally excellent or world leading. Lancaster University’s research is truly international in focus, with research partnerships in over 60 countries around the world.

The 2021 Research Excellence Framework (REF) confirmed Lancaster as a world-leading research university

Chief Scientific Officer

Prof. Muhammad Munir

Prof. Muhammad Munir is a molecular virologist at the Lancaster University with research experience on viral diagnostics, vaccine development and viral pathobiology. Prof. Munir has co-developed an artificial intelligence guided molecular diagnostic platform for SARS-CoV-2 detection which is CE Marked and MHRA approved. The system is being commercialized by Vidiia Ltd. He has developed a novel vaccine against CoVID-19 that blocks transmission and can be administered through the nose.

Meet the rest of our team

Prof. Munir is member of the WHO expert panel on animal models and CoVID-19 vaccines. He has provided expert comment on viruses over 500 times on 18 different TV/Radio channels including CNN, BBC, Sky News, ITV etc.

Get in touch and let us know how we can help.